TIS 0.00% 0.0¢ tissue therapies limited

Capital Raise in Jan before the decision?, page-9

  1. 76 Posts.
    By the end of this week it will be just a month away until our response is submitted then a month after that until an opinion is given, at these prices it’s a buy with a good risk reward payoff depending on what you think a post approval revalued share price will look like. I expect that there will be a steady increase in share price between new years and opinion day until the risk reward payoff is neutral. However the shallow sell side could cause the share price to spike quickly as it did before the last meeting in a session or two.

    Interesting times
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.